Acute kidney injury (AKI) (formerly, acute kidney failure) remains a major problem in critically ill patients, with more than >50% of intensive care unit (ICU) patients being reported to show some evidence of such injury (1) . While sepsis has emerged as the most common cause of AKI (2), it appears that AKI associated with cardiac surgery is perhaps the second most common cause of AKI in the ICU (2, 3). Close to a million patients undergo open-heart surgery every year in developed countries alone (4) . In addition, more and more of these patients receiving complex cardiac surgery, are elderly, and have comorbidities, which predispose to the development of AKI (5, 6) . When cases involve development of even a minor degree of renal dysfunction, mortality rates increase (7) . Patients who develop the need for renal replacement therapy have a mortality rate of 40%-70% (5) . Clearly this is a major health problem in the field of acute medical care. Despite the magnitude of the problem and the fact that cardiac surgery has been a feature of modern hospital practice for several decades, there has been very little progress in the prevention of cardiac surgery-associated acute kidney injury (CSA-AKI) and limited progress in its treatment. Furthermore, there has never been an attempt to gather all available evidence and review it according to an expert-led consensus process to systematically describe what is known and what is unknown about it and what the research agenda should be. This is unfortunate, because it is only when the key issues are identified that research programs can be focused and developed and that resources can be correctly directed. To respond to this need, the Acute Dialysis Quality Initiative (ADQI) group convened its sixth consensus meeting in Vicenza, Italy, in May 2007, and performed a full review of this area with the aim of developing a variety of consensus recommendations in relation to several aspects of CSA-AKI. In particular, the ADQI consensus conference, known as ADQI VI, focused on 4 key aspects: -the epidemiology and prognosis of CSA-AKI, -the pathophysiology of CSA-AKI, -the prevention of CSA-AKI, -the treatment of CSA-AKI.
In this issue of the International Journal of Artificial Organs, we report the deliberations of ADQI VI. We hope that the work of ADQI VI will stimulate future research and practice development with as much vigor and success as that of previous ADQI meetings (8) and that it will also serve as an important educational tool to improve patient care here and now.
